Paulo Brofman
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19. (NCT05433298) | Paulo Brofman | 2022-05-01 |
Track Paulo Brofman automatically
Every clearance here is in the API, with alerts when new ones post.